Publication | Closed Access

Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy

Peripheral NeuropathyHepatologyViral HepatitisRandomized StudyHepatitis BHepatitisChronic Hepatitis BNeurologyMedicine